SMAD4 expression predicts local spread and treatment failure in resected pancreatic cancer

Pancreas
Suguru YamadaYasuhiro Kodera

Abstract

The purpose of this study was to evaluate the prognostic relevance of SMAD4 expression in pancreatic cancer. We analyzed the correlations between SMAD4 expression and clinicopathological parameters and outcome in 174 patients with pancreatic cancer. Specimens were also classified into subtypes reflecting epithelial-to-mesenchymal transition, based on E-cadherin and vimentin. We found that 59.8% (104/174) of patients were SMAD4 and 40.2% (70/174) were SMAD4. Disease-specific survival in patients with SMAD4 was significantly better than that in SMAD4. SMAD4 status was significantly correlated with portal vein invasion, lymph vessel invasion, and perineural invasion and was an independent prognostic factor. SMAD4 was significantly associated with mesenchymal phenotype. The loss of SMAD4 expression was found in 49.4% of patients with no vascular invasion, 61.9% with portal vein invasion, 76.5% with common hepatic artery invasion, and 80.8% with superior mesenteric artery invasion. In addition, the specimens from 59.0% of patients with local recurrence, 66.7% of those with both local and distant recurrence, and 73.7% of those with distant recurrence were SMAD4. The loss of SMAD4 expression is an independent prognostic factor and see...Continue Reading

References

Nov 28, 2002·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Andrew V BiankinSusan M Henshall
Apr 28, 2005·The American Journal of Pathology·Mei WanXu Cao
May 12, 2005·Gastroenterology·Curtis J WrayAndrew M Lowy
Aug 27, 2005·Oncogene·Jiri Zavadil, Erwin P Böttinger
Jun 24, 2006·Annals of Surgery·John L CameronKenneth A Belcher
Feb 18, 2009·Journal of Gastroenterology and Hepatology·Kenji YamaoAtsushi Irisawa
Mar 11, 2009·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Christine A Iacobuzio-DonahueDaniel Laheru
Jul 9, 2009·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Amanda BlackfordRalph H Hruban
Apr 30, 2010·The New England Journal of Medicine·Manuel Hidalgo
Sep 8, 2010·Nature Cell Biology·Muh-Hwa YangKou-Juey Wu

❮ Previous
Next ❯

Citations

Mar 8, 2016·Translational Oncology·Xing ShugangLi Wei
Jun 28, 2016·Pharmacology & Therapeutics·Daniel DelittoSteven J Hughes
Apr 7, 2017·International Journal of Molecular Sciences·Mohammad Aslam Aslam KhanAjay Pratap Singh
May 24, 2017·International Journal of Molecular Sciences·Steffen OrmannsStefan Boeck
Dec 24, 2016·European Journal of Gastroenterology & Hepatology·Přemysl FričMiroslav Zavoral
Jan 27, 2019·Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc·Krishnan K MahadevanVikram Deshpande
Mar 21, 2019·Journal of Gastrointestinal Cancer·Marcus A AlvarezEvan S Glazer
May 21, 2020·International Journal of Molecular Sciences·Julie DardareAlexandre Harlé
Mar 12, 2021·Cellular Oncology (Dordrecht)·S Mazher HussainEvan S Glazer
Sep 23, 2019·Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [et Al.]·Thomas HeldMatthias Löhr
Mar 30, 2021·Radiology. Imaging Cancer·Ajaykumar C MoraniSrinivasa R Prasad

❮ Previous
Next ❯

Related Concepts

Related Feeds

Carcinoma, Ductal

Ductal carcinoma is a malignant neoplasm involving the ductal systems of any of a number of organs, such as the mammary glands, pancreas, prostate or lacrimal gland. Discover the latest research on ductal carcinoma here.

Cadherins and Catenins

Cadherins (named for "calcium-dependent adhesion") are a type of cell adhesion molecule (CAM) that is important in the formation of adherens junctions to bind cells with each other. Catenins are a family of proteins found in complexes with cadherin cell adhesion molecules of animal cells: alpha-catenin can bind to β-catenin and can also bind actin. β-catenin binds the cytoplasmic domain of some cadherins. Discover the latest research on cadherins and catenins here.